BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. (BFNH) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001310488 · BFNH · OTC · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001310488 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
BioForce Nanosciences Holdings, Inc. (OTC: BFNH) has submitted 240 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Consumer Defensive sector company with CIK 0001310488, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is BioForce Nanosciences Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent BioForce Nanosciences Holdings, Inc. 10-K was filed on 2026-04-15 for fiscal year ending 2026. Historical BFNH 10-K annual reports are available from 2004 through 2026.
Investors researching BioForce Nanosciences Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BFNH SEC Filings · 8 questionsBioForce Nanosciences Holdings, Inc. (BFNH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 240 filings and access original documents at no cost. BioForce Nanosciences Holdings, Inc.'s CIK is 0001310488.